Calcineurin inhibitors for psoriasis

Protopic (tacrolimus) ointment and Elidel (pimecrolimus) cream are calcineurin inhibitors. The FDA approved both to treat atopic dermatitis (eczema), not psoriasis, so using either on psoriasis is off-label - a real, documented practice, not an error. They work by blocking calcineurin, a step immune cells need to switch on the inflammatory signals that drive a plaque. Unlike a steroid, they do not thin the skin, which is the reason dermatologists reach for them at all.⌁ Evidence⌁ Evidence

AAD describes these medicines used on plaque psoriasis on the face and other delicate areas including the genitals. They are also used on inverse psoriasis - the armpits, under the breasts, groin, or face - either alone or alongside a topical steroid. Because they do not thin skin the way a steroid can, they suit areas and durations where a strong steroid would carry more risk. People I have heard from find the hardest part is raising a skin-fold or genital patch at all.⌁ Evidence

AAD says most people apply either medicine twice a day. No improvement after six weeks is a signal to check back with your dermatologist - the same check-in window as topical corticosteroids. There is no single published percentage for how many people clear or improve using either drug for psoriasis, since neither has an FDA psoriasis efficacy review behind it.⌁ Evidence

The most common early effects with either Protopic (tacrolimus) or Elidel (pimecrolimus) are burning and itching where you apply it. The tacrolimus label reports burning in roughly 46% to 58% and itching in roughly 41% to 46% of people in its own studies. Most episodes start in the first few days, last minutes, and ease as treatment continues or the skin clears. Both drugs carry an FDA boxed warning against continuous long-term use. Rare cases of lymphoma or skin cancer have been reported, though AAD notes dermatologists have not observed this increased risk in everyday practice. Both labels tell you to minimize sun exposure during treatment and avoid tanning beds, sunlamps, and UV therapy. Call your dermatologist about persistent burning, or anything that feels like more than the expected early reaction.⌁ Evidence⌁ Evidence⌁ Evidence

I could not capture a live retail price. GoodRx returned an access-blocked response to a direct check on 2026-09-08. So I went to the two FDA labels instead. The pimecrolimus cream label cited above is itself a generic, not the original brand Elidel. A separate generic tacrolimus ointment, in both 0.03% and 0.1% strengths, is currently marketed under its own label, distinct from the brand Protopic label cited above. Ask your pharmacy to run both the insurance price and a discount-card price for what you were actually prescribed.⌁ Evidence⌁ Evidence

No reader has sent me a first-hand account of calcineurin inhibitors for psoriasis yet. Until someone does, here is what the label and the studies say about living with it.⌁ Evidence

Keep a simple, dated record: which medicine and strength you are using, which areas you are treating, and when you started. Add a same-conditions photo (same light, distance, and angle) each time. That gives you and your dermatologist something concrete to compare at the six-week check-in AAD describes, rather than relying on memory.⌁ Evidence